Scott Hunter, chief commercial officer of Neurotech, dies
Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3.
“The entire Neurotech family mourns this loss,” the company said in a statement. “On behalf of the board of directors, management team and employees, we extend our deepest sympathies to Scott’s family.”

Hunter joined Neurotech in January 2023 and previously worked at Novartis, Shire and Bausch + Lomb.

“He was an exceptional partner and instrumental in building the commercial strategy and infrastructure. Scott loved his family, friends, sports and spent more than 2 decades in eye care working in rare disease and specialty markets. He will be deeply missed,” Neurotech said in the statement.
Reference:
- Neurotech Pharmaceuticals, Inc. expands executive team with the appointment of Scott Hunter as chief commercial officer. https://www.neurotechpharmaceuticals.com/wp-content/uploads/Neurotech_CCO_PR_FINAL-1.pdf. Published Jan. 10, 2023. Accessed Dec. 5, 2024.